# BlackRock, Inc.: overview

BLK · NYSE · CIK 2012383 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blk.md) · [Financials](/companies/blk/financials.md) · [Filings](/companies/blk/filings.md) · [Insiders](/companies/blk/insiders.md)

Latest reported revenue: [$7.08bn](/filings/0001193125-26-337177.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-337177).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [5,197](/filings/0001193125-25-267043.md) | [5,677 d](/filings/0001193125-26-071966.md) | [5,276](/filings/0001193125-26-208766.md) | [5,423](/filings/0001193125-26-337177.md) | [6,509](/filings/0001193125-25-267043.md) | [7,008 d](/filings/0001193125-26-071966.md) | [6,698](/filings/0001193125-26-208766.md) | [7,084](/filings/0001193125-26-337177.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [38.6%](/filings/0001193125-25-267043.md) | [36.6% d](/filings/0001193125-26-071966.md) | [32.2%](/filings/0001193125-26-208766.md) | [31.9%](/filings/0001193125-26-337177.md) | [30.0%](/filings/0001193125-25-267043.md) | [23.7% d](/filings/0001193125-26-071966.md) | [42.0%](/filings/0001193125-26-208766.md) | [34.7%](/filings/0001193125-26-337177.md) |
| Net margin | % | [31.4%](/filings/0001193125-25-267043.md) | [29.4% d](/filings/0001193125-26-071966.md) | [28.6%](/filings/0001193125-26-208766.md) | [29.4%](/filings/0001193125-26-337177.md) | [20.3%](/filings/0001193125-25-267043.md) | [16.1% d](/filings/0001193125-26-071966.md) | [33.0%](/filings/0001193125-26-208766.md) | [27.0%](/filings/0001193125-26-337177.md) |
| Diluted EPS | $ per share | [10.90](/filings/0001193125-25-267043.md) | not reported | [9.64](/filings/0001193125-26-208766.md) | [10.19](/filings/0001193125-26-337177.md) | [8.43](/filings/0001193125-25-267043.md) | not reported | [14.06](/filings/0001193125-26-208766.md) | [12.19](/filings/0001193125-26-337177.md) |
| Free cash flow | $m | [1,287 d](/filings/0001193125-25-267043.md) | [2,528 d](/filings/0001193125-26-071966.md) | [(1,206)](/filings/0001193125-26-208766.md) | [1,275 d](/filings/0001193125-26-337177.md) | [1,336 d](/filings/0001193125-25-267043.md) | [2,147 d](/filings/0001193125-26-071966.md) | [(1,086)](/filings/0001193125-26-208766.md) | [1,118 d](/filings/0001193125-26-337177.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2022-12-31) | FY (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $bn | [17.9](/filings/0000950170-25-026584.md) | [17.9](/filings/0001193125-26-071966.md) | [20.4](/filings/0001193125-26-071966.md) | [24.2](/filings/0001193125-26-071966.md) |
| Gross margin | % | not reported | not reported | not reported | not reported |
| Operating margin | % | [35.7%](/filings/0000950170-25-026584.md) | [35.1%](/filings/0001193125-26-071966.md) | [37.1%](/filings/0001193125-26-071966.md) | [29.1%](/filings/0001193125-26-071966.md) |
| Net margin | % | [29.0%](/filings/0000950170-25-026584.md) | [30.8%](/filings/0001193125-26-071966.md) | [31.2%](/filings/0001193125-26-071966.md) | [22.9%](/filings/0001193125-26-071966.md) |
| Diluted EPS | $ per share | [33.97](/filings/0000950170-25-026584.md) | [36.51](/filings/0001193125-26-071966.md) | [42.01](/filings/0001193125-26-071966.md) | [35.31](/filings/0001193125-26-071966.md) |
| Free cash flow | $bn | [4.4](/filings/0000950170-25-026584.md) | [3.8](/filings/0001193125-26-071966.md) | [4.7](/filings/0001193125-26-071966.md) | [3.6](/filings/0001193125-26-071966.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/blk/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $9.75bn | 10,137,544 |  | Added +4,768 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.92bn | 9,280,533 |  | Added +39,933 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $6.17bn | 6,414,683 |  | Added +136,020 |
| [Temasek Holdings (Private) Ltd](/funds/1021944.md) | 2026-06-30 | $5.00bn | 5,195,165 |  | Reduced −135,327 |
| [BANK OF AMERICA CORP /DE/](/funds/70858.md) | 2026-06-30 | $4.41bn | 4,585,356 |  | Reduced −647,617 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $4.32bn | 4,495,074 |  | Added +850,406 |
| [Capital Research Global Investors](/funds/1422848.md) | 2026-06-30 | $4.29bn | 4,458,212 |  | Reduced −152,206 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $3.49bn | 3,628,654 |  | Added +96,700 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $3.35bn | 3,487,404 |  | Added +49,858 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.14bn | 3,284,684 |  | Added +30,889 |

## Recent filings

[All 3,919 filings](/companies/blk/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-14 | 06:39 ET | [8-K](/filings/0001193125-26-420979.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-420979 |
| 2026-08-06 | 10:57 ET | [10-Q](/filings/0001193125-26-337177.md) | Quarterly report, period 2026-06-30 | 0001193125-26-337177 |
| 2026-07-15 | 06:33 ET | [8-K](/filings/0001193125-26-304013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-304013 |
| 2026-06-30 | 17:18 ET | [8-K](/filings/0001193125-26-290830.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-290830 |
| 2026-05-22 | 16:30 ET | [8-K](/filings/0001193125-26-237027.md) | 5.07 Shareholder vote results | 0001193125-26-237027 |
| 2026-05-06 | 15:25 ET | [10-Q](/filings/0001193125-26-208766.md) | Quarterly report, period 2026-03-31 | 0001193125-26-208766 |
| 2026-04-14 | 06:35 ET | [8-K](/filings/0001193125-26-153768.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-153768 |
| 2026-04-10 | 16:30 ET | [DEF 14A](/filings/0001308179-26-000262.md) | Proxy statement, period 2026-05-20 | 0001308179-26-000262 |
| 2026-04-03 | 16:05 ET | [8-K](/filings/0001193125-26-142112.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-142112 |
| 2026-02-25 | 16:57 ET | [10-K](/filings/0001193125-26-071966.md) | Annual report, period 2025-12-31 | 0001193125-26-071966 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-071966.md), filed Feb 25, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 2012383
- Tickers: BLK
- Exchange: NYSE
- SIC code: 6211 Security Brokers, Dealers & Flotation Companies
- State of incorporation: DE
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 04:31 ET. No prices; not investment advice.